RVVTF

Revive Therapeutics Ltd.

 
Ordinary Shares International Reporting
OTCQB
Verified Company Profile 6/10/2016
Contact Info
  • 5 Director Court
  • Suite 105
  • Vaughan, ONT L4L 4S5
  • Canada

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Mar 31, 2016 Interim Financial Report
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Canada
Year of Inc. 2012
Employees 3 a/o Nov 20, 2015
Company Officers/Contacts
Fabio Andrea Chianelli CEO
Carmelo Marrelli CFO
Beverly James Incled VP, R&D
Company Directors
Fabio Andrea Chianelli
Service Providers
Accounting/Auditing Firm
MNP LLP
2701 Evans Avenue
8th Floor
Toronto, ONT, M9C 1A3
Canada

Legal Counsel
Peterson & Company LLP
390 Bay Street
Suite#806
Toronto, ONT, M5H 2Y2
Canada

Investor Relations Firm
Not Available
RVVTF Security Details
Share Structure
Market Value1 $2,793,382 a/o Dec 07, 2016
Authorized Shares Unlimited a/o Mar 31, 2016
Outstanding Shares 23,936,437 a/o Mar 31, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Shareholders
Shareholders of Record 24 a/o Nov 20, 2015
Non US Stock Exchange Listing
RVV - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 0 (-100%)
Jan 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security